Michael Vasconcelles

Insider Reports History

Location
C/O Unum Therapeutics, 200 Cambridgepark Dr., Ste. 3100, Cambridge, MA
Signature
/s/ Charles N. York II, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Vasconcelles:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ImmunoGen, Inc. EVP R&D & MEDICAL AFFAIRS Common Stock 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. EVP R&D & MEDICAL AFFAIRS Restricted Stock Unit 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. EVP R&D & MEDICAL AFFAIRS Stock Option (Right to Buy) 0 $0 $5.19 Feb 12, 2024 Direct
Day One Biopharmaceuticals, Inc. Head of Research and Dev. Stock Option (right to buy Common Stock) 346K Jun 16, 2025 Direct
Day One Biopharmaceuticals, Inc. Head of Research and Dev. Restricted Stock Unit (RSU) 226K Jun 16, 2025 Direct
Magenta Therapeutics, Inc. Director Stock Option (Right to Buy) 40K Aug 15, 2022 Direct
Kura Oncology, Inc. Director Option to purchase common stock 28.5K Jun 5, 2025 Direct

Insider Reports Filed by Michael Vasconcelles

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DAWN Day One Biopharmaceuticals, Inc. Jun 16, 2025 2 $0 4 Jun 18, 2025 Head of Research and Dev.
DAWN Day One Biopharmaceuticals, Inc. Jun 16, 2025 0 $0 3 Jun 18, 2025 Head of Research and Dev.
KURA Kura Oncology, Inc. Jun 5, 2025 1 $0 4 Jun 6, 2025 Director
KURA Kura Oncology, Inc. Sep 13, 2024 0 $0 3 Sep 17, 2024 Director
KURA Kura Oncology, Inc. Sep 13, 2024 2 $0 4 Sep 17, 2024 Director
IMGN ImmunoGen, Inc. Feb 12, 2024 3 $0 4 Feb 12, 2024 EVP R&D & MEDICAL AFFAIRS
IMGN ImmunoGen, Inc. Feb 1, 2024 1 $0 4 Feb 5, 2024 EVP R&D & MEDICAL AFFAIRS
IMGN ImmunoGen, Inc. Dec 29, 2023 1 $21.2K 4 Jan 3, 2024 EVP R&D & MEDICAL AFFAIRS
IMGN ImmunoGen, Inc. Dec 29, 2022 1 $0 4 Jan 3, 2023 EVP R&D & MEDICAL AFFAIRS
IMGN ImmunoGen, Inc. Dec 29, 2022 0 $0 3 Jan 3, 2023 EVP R&D & MEDICAL AFFAIRS
DNTH Magenta Therapeutics, Inc. Aug 15, 2022 1 $0 4 Aug 17, 2022 Director
DNTH Magenta Therapeutics, Inc. Aug 15, 2022 0 $0 3 Aug 17, 2022 Director